3.

影响安罗替尼联合替吉奥治疗复发转移性食管鳞癌患者PFS的Cox比例风险回归模型分析

Multivariate analysis of the progression-free survival in the 26 patients after treatment with anlotinib plus S-1

Factors	HR (95%CI)	P
Radical surgery	4.887 (0.676-35.358)	0.116
Radiotherapy	2.329 (0.588-9.228)	0.229
ECOG PS score	0.348 (0.096-1.255)	0.107
Differentiation grade	6.778 (1.997-23.012)	0.002
Distal metastasis	3.628 (0.222-59.398)	0.366
Liver metastasis	0.190 (0.026-1.392)	0.102